Home » GlaxoSmithKline to Sell Quest Shares for $256 Million
GlaxoSmithKline to Sell Quest Shares for $256 Million
GlaxoSmithKline will sell 5.7 million shares of Quest Diagnostics for about $256 million, the London-based pharmaceutical giant said.
Triangle Business Journal
Triangle Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May